Managing PAP adherence for a large and growing patient population poses a significant challenge for DMEs and physicians.

EnsoData’s cutting-edge PAP adherence prediction eliminates the need for manually sorting through countless patients to identify those who need support most.

For over 8 years, EnsoData has revolutionized sleep medicine with innovative artificial intelligence (AI) technology. Our latest product is designed to assist DMEs and referring physicians in prioritizing support for patients who need it most, at the right time, and for the right reason.

"*" indicates required fields

Don't Miss Out! Receive Updates on Our Therapy Adherence Product

Stay in the loop by subscribing below for the latest updates as we approach our Q1 2024 launch.